Hypoxia Suppresses High Fat Diet-Induced Steatosis And Development Of Hepatic Adenomas
Authors Sweeney NW, Gomes CJ, De Armond R, Centuori SM, Parthasarathy S, Martinez JD
Received 29 May 2019
Accepted for publication 1 September 2019
Published 21 October 2019 Volume 2019:7 Pages 53—63
Checked for plagiarism Yes
Review by Single-blind
Peer reviewer comments 2
Editor who approved publication: Prof. Dr. Dörthe Katschinski
Nathan W Sweeney,1 Cecil J Gomes,1 Richard De Armond,2 Sara M Centuori,3 Sairam Parthasarathy,2 Jesse D Martinez3,4
1Cancer Biology Graduate Interdisciplinary Program, University of Arizona, Tucson, AZ, USA; 2University of Arizona Health Sciences Center for Sleep and Circadian Sciences, Division of Pulmonary, Allergy, Critical Care, and Sleep Medicine, Department of Medicine, University of Arizona, Tucson, AZ, USA; 3University of Arizona Cancer Center, University of Arizona, Tucson, AZ, USA; 4Department of Cellular and Molecular Medicine, Cell and Molecular Medicine, University of Arizona, Tucson, AZ, USA
Correspondence: Jesse D Martinez
University of Arizona Cancer Center, 1515 N. Campbell Avenue, Tucson, AZ 85724, USA
Purpose: Nonalcoholic fatty liver disease (NAFLD) is considered the most common form of silent liver disease in the United States and obesity is associated with increased risk of NAFLD. Obstructive sleep apnea (OSA) which is common in obese individuals is associated with a greater incidence of NAFLD, which in turn, increases the risk for hepatocellular carcinoma (HCC). It is unclear how obesity, OSA and NAFLD interrelate nor how they collectively contribute to an increased risk for developing HCC.
Patients and methods: Male BALB/c mice were exposed to diethylnitrosamine and phenobarbital followed by 48 weeks of either standard chow diet (chow), chow with hypoxia, high-fat diet, or a combination of hypoxia and high-fat diet. We noninvasively monitored tumor development using micro-CT imaging. We tracked the total weight gained throughout the study. We evaluated liver histology, fat accumulation, carbonic anhydrase 9 (CA9) and hypoxia-inducible factor 1-alpha (HIF-1α) expression, as well as, serum aspartate aminotransferase (AST) and alanine aminotransferase (ALT).
Results: A high-fat diet without hypoxia led to the development of obesity that induced hepatic steatosis and promoted tumorigenesis. Animals on a high-fat diet and that were also exposed to hypoxia had lower total weight gain, lower steatosis, lower serum AST and ALT levels, and fewer number of hepatic adenomas than a high-fat diet without hypoxia.
Conclusion: These findings suggest that hypoxia abrogates obesity, hepatic steatosis, and hepatic tumorigenesis related to a high-fat diet.
Keywords: hypoxia, diet, high fat, fatty liver
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]